Company Filing History:

4 out of 3,540

The United States of America, as Represented by the Secretary, Department of Health and Human Services

Years Active: 2001-2015

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9168297 - Regulation of skin pigmentation by neuregulin-1 (NRG-1) (2015-10-27),

2. 8946291 - Compositions and methods for treating pigmentary conditions and melanoma (2015-02-03),

3. 8476236 - Treatment of skin conditions by Dickkopf1 (DKK1) (2013-07-02),

4. 8198244 - Regulation of skin characteristics by DICKKOPF1 (DKK1) (2012-06-12),

5. 7498310 - Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation (2009-03-03),

6. 6852699 - COSMETIC OR DERMATOLOGICAL PREPARATIONS COMPRISING OLIGOPEPTIDES FOR LIGHTENING THE SKIN OF AGE MARKS AND/OR FOR PREVENTING TANNING OF THE SKIN, IN PARTICULAR TANNING OF THE SKIN CAUSED BY UV RADIATION (2005-02-08),

7. 6296857 - Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation (2001-10-02),

Title: Vincent J Hearing: Innovator in Skin Pigmentation and Melanoma Treatment

Introduction

Vincent J Hearing is a notable inventor based in Leesburg, VA (US), recognized for his contributions to the field of dermatology and cancer treatment. He holds a total of 7 patents, focusing on innovative methods to regulate skin pigmentation and treat melanoma.

Latest Patents

One of his latest patents involves the regulation of skin pigmentation by neuregulin-1 (NRG-1). This patent discloses compositions and methods for modulating the pigmentation and proliferation of melanocytes, which can be crucial in preventing or treating skin disorders, including skin cancer. The method includes contacting a melanocyte with an agent that modulates NRG-1 activity, thereby influencing pigmentation. Another significant patent addresses compositions and methods for treating pigmentary conditions and melanoma. This includes administering SOX9 to treat melanoma and using inhibitors of SOX9 activity to address hyperpigmentary conditions. These innovative methods highlight his commitment to advancing skin health and cancer treatment.

Career Highlights

Vincent J Hearing has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Beiersdorf AG. His work in these institutions has significantly contributed to his research and development in skin health and cancer therapies.

Collaborations

He has collaborated with notable professionals in his field, including Heiner Max and Thierry Passeron. These collaborations have likely enriched his research and expanded the impact of his innovations.

Conclusion

Vincent J Hearing's work in skin pigmentation and melanoma treatment showcases his dedication to improving health outcomes through innovative research. His patents reflect a significant advancement in dermatological science and cancer treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com